These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30282364)

  • 1. Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis.
    Doig AJ
    J Alzheimers Dis; 2018; 66(1):25-36. PubMed ID: 30282364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dark side of Alzheimer's disease: unstructured biology of proteins from the amyloid cascade signaling pathway.
    Gadhave K; Gehi BR; Kumar P; Xue B; Uversky VN; Giri R
    Cell Mol Life Sci; 2020 Oct; 77(20):4163-4208. PubMed ID: 31894361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β and Tau at the Crossroads of Alzheimer's Disease.
    Gallardo G; Holtzman DM
    Adv Exp Med Biol; 2019; 1184():187-203. PubMed ID: 32096039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.
    Cho JE; Kim JR
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):222-33. PubMed ID: 21834780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. βAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer's Disease.
    Audrain M; Souchet B; Alves S; Fol R; Viode A; Haddjeri A; Tada S; Orefice NS; Joséphine C; Bemelmans AP; Delzescaux T; Déglon N; Hantraye P; Akwa Y; Becher F; Billard JM; Potier B; Dutar P; Cartier N; Braudeau J
    Cereb Cortex; 2018 Nov; 28(11):3976-3993. PubMed ID: 29048465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
    Ashrafian H; Zadeh EH; Khan RH
    Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
    Dunys J; Valverde A; Checler F
    J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
    Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
    eNeuro; 2017; 4(2):. PubMed ID: 28374012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connecting the Dots: Linking the Biochemical to Morphological Transitions in Alzheimer's Disease.
    Baig AM
    ACS Chem Neurosci; 2019 Jan; 10(1):21-24. PubMed ID: 30160095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies.
    Volloch V; Rits-Volloch S
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-β, tau, and the cholinergic system in Alzheimer's disease: seeking direction in a tangle of clues.
    Majdi A; Sadigh-Eteghad S; Rahigh Aghsan S; Farajdokht F; Vatandoust SM; Namvaran A; Mahmoudi J
    Rev Neurosci; 2020 May; 31(4):391-413. PubMed ID: 32017704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation.
    Lin LF; Luo HM
    Neurosci Bull; 2011 Feb; 27(1):53-60. PubMed ID: 21270904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.